Abstract
Differences in the expression of non-motor symptoms (NMS) by Parkinson’s disease (PD) patients may have important implications for their management and prognosis. Gender is a basic epidemiological variable that could influence such expression. The present study evaluated the prevalence and severity of NMS by gender in an international sample of 951 PD patients, 62.63% males, using the non-motor symptoms scale (NMSS). Assessments for motor impairment and complications, global severity, and health state were also applied. All disease stages were included. No significant gender differences were found for demographic and clinical characteristics. For the entire sample, the most prevalent symptoms were Nocturia (64.88%) and Fatigue (62.78%) and the most prevalent affected domains were Sleep/Fatigue (84.02%) and Miscellaneous (82.44%). Fatigue, feelings of nervousness, feelings of sadness, constipation, restless legs, and pain were more common and severe in women. On the contrary, daytime sleepiness, dribbling saliva, interest in sex, and problems having sex were more prevalent and severe in men. Regarding the NMSS domains, Mood/Apathy and Miscellaneous problems (pain, loss of taste or smell, weight change, and excessive sweating) were predominantly affected in women and Sexual dysfunction in men. No other significant differences by gender were observed. To conclude, in this study significant differences between men and women in prevalence and severity of fatigue, mood, sexual and digestive problems, pain, restless legs, and daytime sleepiness were found. Gender-related patterns of NMS involvement may be relevant for clinical trials in PD.
Similar content being viewed by others
References
Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson’s disease: time for a comprehensive assessment. Curr Neurol Neurosci Rep 5:275–283
Hely MA, Morris JGL, Reid WGJ, Trafficante R (2005) Sydney multicenter study of Parkinson’s disease: non-l-dopa-responsive problems dominate at 15 years. Mov Disord 20:190–199
Chaudhuri KR, Healy D, Schapira AHV (2006) The non-motor symptoms of Parkinson’s disease. Diagnosis and management. Lancet Neurol 5:235–245
Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting: Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629
Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 8:193–197
Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S et al (2010) The non declaration of non motor symptoms of Parkinson’s disease to health care professionals: an international study using the non motor symptoms questionnaire. Mov Disord 25:704–709
Martinez-Martin P, Marinus J, van Hilten B (2009) Assessment tools for non-motor symptoms of Parkinson’s disease. In: Chaudhuri KR, Tolosa E, Schapira A, Poewe W (eds) Non-motor symptoms of Parkinson’s disease. Oxford University Press, Oxford, pp 47–58
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170
Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ et al (2009) International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 73:1584–1591
Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22:1901–1911
Kasten M, Chade A, Tanner CM (2007) Epidemiology of Parkinson’s disease. In: Koller WC, Melamed E (eds) Parkinson’s Disease and Related Disorders. Part I. Handbook of Clinical Neurology vol. 83, 3rd edn. Elsevier BV, Amsterdam, pp 129–151
Lyons K, Hubble J, Tröster A, Pahwa R, Koller WC (1998) Gender differences in Parkinson’s disease. Clin Neuropharmacol 21:118–121
Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM (2000) Gender differences in Parkinson’s disease symptom profile. Acta Neurol Scand 102:37–43
Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA et al (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015–1022
Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ (2005) Gender and the Parkinson’s disease phenotype. J Neurol 252:1201–1205
Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S et al (2007) Gender differences in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78:819–824
Ehrt U, Brønnick K, De Deyn PP, Emre M, Tekin S, Lane R et al (2007) Subthreshold depression in patients with Parkinson’s disease and dementia–clinical and demographic correlates. Int J Geriatr Psychiatry 22:980–985
Celikel E, Ozel-Kizil ET, Akbostanci MC, Cevik A (2008) Assessment of sexual dysfunction in patients with Parkinson’s disease: a case–control study. Eur J Neurol 15:1168–1172
Solimeo S (2008) Sex and gender in older adults’ experience of Parkinson’s disease. J Gerontol Soc Sci 63B:S42–S48
Miller IN, Cronin-Golomb A (2010) Gender differences in Parkinson’s disease: clinical characteristics and cognition. Mov Disord 25:2695–2703
Krishnan S, Sarma G, Sarma S, Kishore A (2011) Do Nonmotor Symptoms in Parkinson’s disease differ from normal aging? Mov Disord. doi:10.1002/mds.23826
Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet 373:2055–2066
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442
Marinus J, Visser M, Stiggelbout AM, Martin Rabey J, Martinez-Martin P, Bonuccelli U et al (2004) A short scale for the assessment of motor impairments and disabilities in Parkinson’s disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 75:388–395
Martinez-Martin P, Benito-Leon J, Burguera JA, Castro A, Linazasoro G, Martinez-Castrillo JC et al (2005) The SCOPA-Motor Scale for assessment of Parkinson’s disease is a consistent and valid measure. J Clin Epidemiol 58:674–679
Martinez-Martin P, Forjaz MJ, Cubo E, Frades B, de Pedro Cuesta J, Project Members ELEP (2006) Global versus factor-related impression of severity in Parkinson’s disease: A new clinimetric index (CISI-PD). Mov Disord 21:208–214
Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, de Pedro J, n Longitudinal PD, Group Patient Study (2009) The clinical impression of severity index for Parkinson’s disease: international validation study. Mov Disord 24:211–217
Group EuroQol (1990) EuroQol- a new facility for the measurement of health related quality of life. Health Policy 16:199–208
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The PDQ-8: development and validation of a short-form Parkinson’s disease questionnaire. Psychol Health 12:805–814
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 57:289–300
Friedman JH, Friedman H (1993) Fatigue in Parkinson’s disease. Neurology 43:2016–2018
Martinez-Martin P, Catalan MJ, Benito-Leon J et al (2006) Impact of fatigue in Parkinson’s disease: the fatigue impact scale for daily use (D-FIS). Qual Life Res 15:597–606
Friedman JH, Brown RG, Comella C et al (2007) Fatigue in Parkinson’s disease: a review. Mov Disord 22:297–308
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24:1641–1649
Beiske AG, Loge JH, Hjermstad MJ, Svensson E (2010) Fatigue in Parkinson’s disease: prevalence and associated factors. Mov Disord 25:2456–2460
Stein MB, Heuser IJ, Juncos JL, Uhde TW (1990) Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 147:217–220
Richard IH (2005) Anxiety disorders in Parkinson’s disease. Adv Neurol 96:42–55
Weintraub D, Burn DJ (2011) Parkinson’s disease: the quintessential neuropsychiatric disorder. Mov Disord 26:1022–1031
Blonder LX, Slevin JT (2011) Emotional dysfunction in Parkinson’s disease. Behav Neurol 24:201–217
Martinez-Martin P, Damian J (2010) Depression and anxiety in Parkinson’s disease. Nature Rev Neurol 6:243–245
Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE (2011) Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord 26:484–492
Carod-Artal FJ, Vargas AP, Martínez-Martín P (2007) Determinants of quality of life in Brazilian patients with Parkinson’s disease. Mov Disord 22:1408–1415
Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García-Sánchez C, Gironell A, Study Trapecio Group (2008) Prevalence and correlates of neuropsychiatric symptoms in Parkinson’s disease without dementia. Mov Disord 23:1889–1896
Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008) A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 23:183–189
Rojo A, Aguilar M, Garolera MT, Cubo E, Navas I, Quintana S (2003) Depression in Parkinson’s disease: clinical correlates and outcome. Parkinsonism Relat Disord 10:23–28
Krogh K, Ostergaard K, Sabroe S, Laurberg S (2008) Clinical aspects of bowel symptoms in Parkinson’s disease. Acta Neurol Scand 117:60–64
Kamm MA (2003) Constipation and its management. Br Med J 327:459–460
Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC (1986) Pain in Parkinson’s disease. Mov Disord 1:45–49
Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A et al (2008) Pain as a nonmotor symptom of Parkinson disease. Arch Neurol 65:1191–1194
Beiske AG, Loge JH, Rønningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141:173–177
Zambito Marsala S, Tinazzi M, Vitaliani R, Recchia S, Fabris F, Marchini C et al (2011) Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. J Neurol 258:627–633
Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M (2011) Pain is common in Parkinson’s disease. Clin Neurol Neurosurg 113:11–13
Gomez-Esteban JC, Zarranz JJ, Tijero B, Velasco F, Barcena J, Rouco I et al (2007) Restless legs syndrome in Parkinson’s disease. Mov Disord 22:1912–1916
Peralta CM, Frauscher B, Seppi K, Wolf E, Wenning GK, Högl B et al (2009) Restless legs syndrome in Parkinson’s disease. Mov Disord 24:2076–2080
Verbaan D, van Rooden SM, van Hilten JJ, Rijsman RM (2010) Prevalence and clinical profile of restless legs syndrome in Parkinson’s disease. Mov Disord 25:2142–2147
Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 57:1392–1396
Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland A, Larsen JP (2006) Excessive daytime sleepiness in Parkinson disease. Is it the drugs or the disease? Neurology 67:853–858
Stavitsky K, Cronin-Golomb A (2011) Sleep quality in Parkinson disease: an examination of clinical variables. Cogn Behav Neurol 24:43–49
Merello M (2008) Sialorrhoea and drooling in patients with Parkinson’s disease: epidemiology and management. Drugs Aging 25:1007–1019
Wüllner U, Schmitz-Hübsch T, Antony G, Fimmers R, Spottke A, Oertel WH et al (2007) Autonomic dysfunction in 3414 Parkinson’s disease patients enrolled in the German Network on Parkinson’s disease (KNP e.V.): the effect of ageing. Eur J Neurol 14:1405–1408
Mshana G, Dotchin CL, Walker RW (2011) We call it the shaking illness: perceptions and experiences of Parkinson’s disease in rural northern Tanzania. BMC Public Health 11:219
Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474
Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 62:155–198
Fuhrer R, Wessely S (1995) The epidemiology of fatigue and depression: a French primary-care study. Psychol Med 25:895–905
Sharpe M, Wilks D (2002) Fatigue. Br Med J 325:480–483
Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA (2001) Generalized anxiety disorder in women. Psychiatr Clin North Am 24:165–178
Tyrer P, Baldwin D (2006) Generalised anxiety disorder. Lancet 368:2156–2166
Djernes JK (2006) Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 113:372–387
Vink D, Aartsen MJ, Comijs HC, Heymans MW, Penninx BW, Stek ML et al (2009) Onset of anxiety and depression in the aging population: comparison of risk factors in a 9-year prospective study. Am J Geriatr Psychiatry 17:642–652
Mourão AF, Blyth FM, Branco JC (2010) Generalised musculoskeletal pain syndromes. Best Pract Res Clin Rheumatol 24:829–840
Leresche L (2011) Defining gender disparities in pain management. Clin Orthop Relat Res 469:1871–1877
Yeh P, Walters AS, Tsuang JW (2011) Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath. doi:10.1007/s11325-011-0606-x
Krishnan V, Collop NA (2006) Gender differences in sleep disorders. Curr Opin Pulm Med 12:383–389
Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T et al (2009) Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24:1468–1474
Reddy P, Martinez-Martin P, Antonini A, Odin P, Martin A, Calandrella D (2011) Comparison of non-motor effects of subcutaneous apomorphine infusion and intrajejunal levodopa infusion in advanced Parkinson’s disease. Eur J Neurol 18(Suppl 2):242
Conflicts of interest
The authors have no conflicts of interest or competing financial interests with regards to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martinez-Martin, P., Falup Pecurariu, C., Odin, P. et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease. J Neurol 259, 1639–1647 (2012). https://doi.org/10.1007/s00415-011-6392-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-6392-3